1.〔復(fù)carcinomas或carcinomata〕癌：上皮細(xì)胞形成的惡性瘤，向周圍組織浸潤并發(fā)生轉(zhuǎn)移

1.癌

1 . 癌

...織來源命名，良性瘤在其來源組織名稱后加一“瘤”字，惡性腫瘤則在其來源組織名稱后加上“癌”或“肉瘤”，來源于上皮組織的統(tǒng)稱為癌（carcinoma），從間葉組織發(fā)生的惡性腫瘤統(tǒng)稱為肉瘤（sarcoma）。

2 . 癌的

carcinoma栓子, carcinoma癌的, carcinoma癌.肝細(xì)胞

3 . 腫瘤

surgical management of cervical tracheal carcinoma., 頸段氣管腫瘤的外科治療.

4 . 癌組織

Study on ras protein in human esophageal squamous cell carcinomain northern China ., 食管鱗狀細(xì)胞癌組織中 ras 蛋白的研究.

1 . 支氣管癌

they are basal cell cancer ; bile duct cancer ; brain tumor ( metastatic , primary , secondary ) ; breast cancer ; lung cancer , bronchogenic carcinoma ; carcinoma of the stomach and so on .它們是基底細(xì)胞癌、膽管癌、腦瘤（轉(zhuǎn)移性的、原發(fā)性的、繼發(fā)性的)、乳腺癌、肺癌、支氣管癌、胃癌等。

1 . 癌細(xì)胞和癌

I would like to know that wheather a direct stimulus by electicity on the adrenergic nere can the death of carcinoma cell and carcinoma tissue or not ?我真想知道對交感神經(jīng)的直接電刺激是否能導(dǎo)致癌細(xì)胞和癌組織死亡？

1 . 卵巢癌和乳腺癌

longtime and low dose HRT has no significant risk of endometrial carcinoma , carcinoma and carcinoma .小劑量HRT對發(fā)生子宮內(nèi)膜癌、卵巢癌和乳腺癌的危險(xiǎn)性無明顯影響；

1 . 癌的組織

by reviewing related literature , we realized that in the neck region , over-expression of OPN was found only in dysplastic and squamous cell carcinoma ( SCC ) and not in normal mucosa .大量的文獻(xiàn)報(bào)道，OPN在頭頸部的正常黏膜中無表達(dá)，而在發(fā)育不良和鱗狀細(xì)胞癌的組織中呈陽性表達(dá)，且表達(dá)水平與腫瘤的轉(zhuǎn)移和惡性程度有關(guān)。

2 . 癌標(biāo)本

methods : samples from 20 cases of adenoid cystic carcinoma ( ACC ) and 18 cases of mucoepidermoid carcinoma ( MEC ) were immunohistochemical stained with S100 antibody .方法：選取20例腺樣囊性癌和18例粘液表皮樣癌標(biāo)本，分別進(jìn)行S100免疫組化染色。